|
Women's Healthy Lifestyle Project: Cardiovascular Risk Factors and Menopause Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified health advice, visits or treatment with a real mD. We are not doctors. Always consult your doctor about Women's Healthy Lifestyle Project: Cardiovascular Risk Factors and Menopause conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Women's Healthy Lifestyle Project: Cardiovascular Risk Factors and Menopause Clinical research trials and Women's Healthy Lifestyle Project: Cardiovascular Risk Factors and Menopause healthcare trials happen in many of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new drugs. The purpose of the studies / projects is to solve particular human medical questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to discover cures for all varieties of conditions, such as Women's Healthy Lifestyle Project: Cardiovascular Risk Factors and Menopause. Women's Healthy Lifestyle Project: Cardiovascular Risk Factors and Menopause Clinical Trials and other clinical trials allow volunteers to have health treatment alternatives before they are available to the masses. Some times the human subjects obtain treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Women's Healthy Lifestyle Project: Cardiovascular Risk Factors and Menopause clinical trial. Test subjects oftentimes receive the most effective healthcare possible for their Women's Healthy Lifestyle Project: Cardiovascular Risk Factors and Menopause condition. Dangers are a reality, however, and may include extra or frequent physician visits, healthcare dangers (possibly life-jeopardising), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "W" Clinical Trials Conditions > Women's Healthy Lifestyle Project: Cardiovascular Risk Factors and Menopause  Women's Healthy Lifestyle Project: Cardiovascular Risk Factors and Menopause
Women's Healthy Lifestyle Project: Cardiovascular Risk Factors and Menopause
For Condition: Cardiovascular Diseases,Diabetes Mellitus,Heart Diseases,Hypercholesterolemia,Hypertension,Obesity,Menopause,Postmenopause
Status: Completed
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: To determine if the increase in low density lipoprotein (LDL) cholesterol at the time of menopause could be ameliorated or prevented by an intensive dietary intervention. Also, to prevent the increase in body weight and associated changes in insulin, glucose, blood pressure, triglycerides, and high density lipoprotein cholesterol during the peri- to postmenopausal period.
Details: BACKGROUND: Coronary heart disease causes almost as many deaths in women as it does in men, with approximately 90 percent of the deaths in women occurring after the age of 50. There are substantial increases in coronary heart disease risk factors at the time of the menopause, especially increases in total cholesterol and low density lipoprotein cholesterol, that may well contribute to the increased risk of coronary heart disease. DESIGN NARRATIVE: A total of 275 premenopausal women were randomized to a control group and 260 women into a lifestyle intervention group, a cognitive-behavioral program which was designed to reduce total dietary fat to less than 25 percent of calories, saturated fat to less than 7 percent of calories, and cholesterol to less than 100 mg. All women were given a weight loss goal of five to 15 pounds, depending on baseline weight status and asked to reduce calorie intake to 1300 kcal until weight goal was achieved. The intervention included an intensive group program during the first six months and follow-up individual/group sessions from six through 54 months. The primary endpoints of the trial were difference in the change in LDL cholesterol and weight between intervention and assessment-only groups at the end of the trial. The intervention also compared whether the dietary intervention could prevent the increase in low density lipoprotein cholesterol and the weight gain observed at this period of a woman's life; whether dietary intervention affected the age of menopause or the percent of women using hormone therapy or having hysterectomy; and whether the dietary intervention had adverse effects on menopausal symptomatology, endogenous hormones, and bone mineral density. The Office of Research on Women's Health provided supplemental funds to measure hemostatic factors, including fibrinogen, factor VIIc and antigen, antithrombin III and PAI-1 in plasma samples for all subjects at baseline. The supplement allowed a longitudinal description of changes in hemostatic factors that appeared to occur during the perimenopausal transition and an investigation of whether diet and diet intervention altered the pattern of hemostatic changes observed at menopause. Beginning in February 1996, the trial was extended for four years through January 2000 to provide for data analysis and an additional follow-up of at least 4.5 years for all participants.
Eligibility:
Study Type: Interventional, Prevention, Randomized
Minimum Age/Maximum Age: 45 Years/50 Years
Genders: Female
Protocol Entry Criteria: Premenopausal women, ages 45-50 at entry.
Total Enrollment:
Location and Contact Information:
Additional Information:
Study ID Numbers: 75;
Study Start Date: February 1992
Record last reviewed: April 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00000532
Other Hypercholesterolemia Studies:
1. Mutations, Hormone Therapy (HRT) and Venous Thromboembolism
2. Women's Health Trial: Feasibility Study in Minority Populations
3. Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)
4. Women's Healthy Lifestyle Project: Cardiovascular Risk Factors and Menopause
5. Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women with Chronic Infections
Related Studies:
Other Hypercholesterolemia Clinical Trials
Other Clinical Trials
Other Clinical Trials
Women's Healthy Lifestyle Project: Cardiovascular Risk Factors and Menopause
|
|
|
|
|
|
|
|
